Company Overview
- Website
- tiximed.com
- Employees
- 4
- Industry
- Biotech/Healthcare
Recent News & Media
TIXiMED Announces Successful Completion of a Phase 1 Study of its Novel Oral Disease-Modifying Type 1 Diabetes Therapy
- May 29, 2025
- biospace.com
Startup Advances Dosing Study of Oral Therapy for Type 1 Diabetes
- May 5, 2025
- managedhealthcareexecutive.com
Cardiovascular detection startup launches out of UAB
- Jan 21, 2025
- bizjournals.com
TIXiMED Announces a $2.65M Program-Related Investment from the Helmsley Charitable Trust to Initiate Clinical Trials of Its Novel Oral Therapy for Beta Cell Survival and Function
- Dec 19, 2024
- businesswire.com
Type 1 diabetes: UAB startup gains FDA clearance to test novel oral drug
- Jul 31, 2024
- uab.edu
Type 1 diabetes: UAB startup gains FDA clearance to test novel oral drug
- Jul 31, 2024
- uab.edu
Company Leadership
Companies Similar to TIXiMED
Analyze industry trends and opportunities by examining competitors and companies comparable to TIXiMED, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| Buffalo, NY | ||||
| 4 | Chandler, AZ | 2014 | ||
| 6 | Fort Worth, TX | |||
| 23 | Gainesville, FL | |||
| 4 | Marietta, GA |